Literature DB >> 11250655

Differential responsiveness of intestinal epithelial cells to 1,25-dihydroxyvitamin D3--role of protein kinase C.

H J Armbrecht1, M A Boltz, T L Hodam, V B Kumar.   

Abstract

Non-transformed rat intestinal epithelial cell (IEC) lines were used to study the action of 1,25-dihydroxyvitamin D(3) (1,25(OH)2D) in the intestine. The capacity of 1,25(OH)2D to increase the expression of the cytochrome P450 component of the vitamin D 24-hydroxylase (CYP24) was determined in IEC-6 and IEC-18 cell lines. In IEC-6 cells, which are derived from crypt cells isolated from the whole small intestine, 1,25(OH)2D markedly increased expression of CYP24 protein and mRNA within 12 h. In contrast, in IEC-18 cells, which are derived from crypt cells from the ileum only, 1,25(OH)2D did not increase expression of CYP24 until 24-48 h. The maximal levels of CYP24 mRNA seen in the IEC-18 cells were only 31% of the maximal levels seen in the IEC-6 cells. In the presence of 1,25(OH)2D, phorbol esters rapidly increased CYP24 mRNA levels in IEC-18 cells from almost undetectable to levels seen in IEC-6 cells. Protein kinase inhibitors abolished the stimulation by 1,25(OH)2D and by phorbol esters in both cell lines. Stimulation of mRNA levels by phorbol esters required new protein synthesis but stimulation by 1,25(OH)2D did not. These studies demonstrated that the rapid action of 1,25(OH)2D in IEC-6 cells is related to the activation of protein kinase C, an event which is missing in the IEC-18 cells. This differential response to 1,25(OH)2D probably takes place at a post-receptor site, since the number of vitamin D receptors in each cell line was found to be similar.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250655     DOI: 10.1677/joe.0.1690145

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site.

Authors:  Barbara K Nutchey; Josef S Kaplan; Prem P Dwivedi; John L Omdahl; Antonio Ferrante; Brian K May; Charles S T Hii
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

2.  Phorbol esters enhance 1α,25-dihydroxyvitamin D3-regulated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) gene expression through ERK-mediated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells.

Authors:  Yan Jiang; James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2012-03-28       Impact factor: 4.102

3.  Effect of phorbol 12-myristate 13-acetate activated signaling pathways on 1α, 25 dihydroxyvitamin D3 regulated human 25-hydroxyvitamin D3 24-hydroxylase gene expression in differentiated Caco-2 cells.

Authors:  Yan Jiang; James C Fleet
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

4.  Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.

Authors:  Min Cui; Yan Zhao; Kenneth W Hance; Andrew Shao; Richard J Wood; James C Fleet
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

5.  The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2.

Authors:  Min Cui; Anna Klopot; Yan Jiang; James C Fleet
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

6.  Matrix extracellular phosphoglycoprotein inhibits phosphate transport.

Authors:  Joanne Marks; Linda J Churchill; Edward S Debnam; Robert J Unwin
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

7.  Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3.

Authors:  Izuru Kurahashi; Ayako Matsunuma; Tetsuya Kawane; Masatoshi Abe; Noboru Horiuchi
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.